The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex several-stage synthetic process. Early routes focused on amino acid chain portion coupling, utilizing https://ronaldgcdr260499.blogtov.com/21392032/synthesis-and-study-uses-of-retatrutide